Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone and/or melatonin for sleep disorders after traumatic brain injury
IRCT20241121063793N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in sleep disorder due to traumatic brain injury (SWD-TBI) comparing Trazodone, Melatonin and Trazodone + melatonin (3 arms). Started Jan 2025; status: completed.
02
Drugs
trazodonemelatonin
03
Conditions
sleep disorder due to traumatic brain injury (SWD-TBI)
Beyond the preview
Go deeper on IRCT20241121063793N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241121063793N1.